News

28 April / 2020

Chondroitin-AKOS in new packaging

  In  April  Sintez OJSC issued the first batch of capsules Chondroitin-AKOS in modern packaging, and by the end of May 70K of packs with the renewed design will have come off the assembly line of the Company to be sent to the shelves of the Russian pharmacies.

  The Chondroitin-AKOS pack is visually divided into two parts: one side contains the main information about the product – name, dosage, and application, and the other one contains an image of a human, a recognisable and simple element of the visual identification of the brand. As it has been conceived by the marketers, it symbolizes the manufacturing company care for a patient or buyer.

  It should be mentioned that Chondroitin-AKOS is one of the retail market leaders in the chondroprotector segment. The medicinal product is available without prescription, but it is necessary to consult a specialist prior to application.

  In 2020 Sintez OJSC will continue to conduct a rebranding of Generics from its product range and soon it is going to bring Chondroitin-AKOS, Aciclovir-AKOS, Clotrimazole-AKOS salves in new packaging, and a range of anaesthetic products to the market.

   Sintez OJSC is one of the largest companies of the Russian pharmaceutical industry. The shareholders are Sistema Joint Stock Financial Corporation and Nacimbio Joint Stock Company of Rostec State Corporation.